Inhibitory effects of Ecklonia cava extract on high glucose-induced hepatic stellate cell activation

Marine Drugs

Volumn 9, Issue 12, 2011, Pages 2793-2808

  Yokogawa, Kumiko ^a   Matsui Yuasa, Isao ^a,b   Tamura, Akiko ^a   Terada, Masaki ^c   Kojima Yuasa, Akiko ^a  

^a Osaka Prefecture University   (Japan)

^b WAKAYAMA UNIVERSITY   (Japan)

^c JP Renew Distributors LLC   (United States)

Author keywords

Ecklonia cava; Hepatic stellate cells; High glucose; Reactive oxygen species; Transforming growth factor ; Type I collagen

Indexed keywords

ALGAL EXTRACT; ALPHA SMOOTH MUSCLE ACTIN; CELL MARKER; COLLAGEN TYPE 1; ECKLONIA CAVA EXTRACT; GLUCOSE; GLUTATHIONE; LIVER PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BROWN ALGA; CELL ACTIVATION; CELL ISOLATION; CELL LEVEL; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ECKLONIA CAVA; LIVER CELL; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STELLATE CELL;

ECKLONIA CAVA; PHAEOPHYCEAE;

EID: 84855233901     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9122793     Document Type: Article

References (39)

1. Poonawala, A.; Nair, S.P.; Thuluvath, P.J. Prevalence of obesity and diabetes inpatients with cryptogenic cirrhosis: A case-control study. Hepatology 2000, 32, 689-692.
2. Tellez-Avila, F.I.; Sanchez-Avila, F.; Garcia-Saenz-de-Sicilia, M.; Chaves-Tapia, N.C.; Franco-Guzman, A.M.; Lopez-Arce, G.; Cerda-Contreras, E.; Uribe, M. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. World J. Gastroenterol. 2008, 14, 4771-4775.
3. Picardi, A.; D'Avola, D.; Gentolucci, U.V.; Galati, G.; Fiori, E.; Spataro, S.; Afeltra, A. Diabetes in chronic liver disease: Old concepts to new evidence. Diabetes Metab. Res. Rev. 2006, 22, 274-283. (Pubitemid 44070503)
4. Iwamoto, K.; Kanno, K.; Hyogo, H.; Yamagishi, S.; Takeuchi, M.; Tazuma, S.; Chayama, K. Advanced glycation and products enhance the proliferation and activation of hepatic stellate cells. J. Gastroenterol. 2008, 43, 298-304. (Pubitemid 351650040)
5. Ziyadeh, F.N.; Sharma, K.; Erickse, M.; Wolf, G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J. Clin. Invest. 1994, 93, 536-542. (Pubitemid 24072793)
6. Sugimoto, R.; Enjoji, M.; Kohjima, M.; Turuta, S.; Fukushima, M.; Iwao, M.; Sonta, T.; Kotoh, K.; Inoguchi, T.; Nakamura, M. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int. 2005, 25, 1018-1025.
7. Svegliati-Baroni, G.; Saccomanno, S.; van Goor, H.; Jansen, P.; Benedetti, A.; Moshage, H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 2001, 21, 1-12. (Pubitemid 32112013)
8. Hui, A.Y.; Friedman, S.L. Molecular basis of hepatic fibrosis. Expert Rev. Mol. Med. 2003, 5, 1-23.
9. Li, Y.; Qian, Z.-J.; Ryu, B.; Lee, S.-H.; Kim, M.-M.; Kim, S.-K. Chemical constituents and its antioxidant properties in vitro: An edible marine alga, Ecklonia cava. Bioorg. Med. Chem. 2009, 17, 1963-1973.
10. Kang, H.S.; Chung, H.Y.; Kim, J.Y.; Son, B.W.; Jung, H.A.; Choi, J.S. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch. Pharm. Res. 2004, 27, 194-198.
11. Kang, K.; Park, Y.; Hwang, H.J.; Kim, S.H.; Lee, J.G.; Shin, H.C. Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors. Arch. Pharm. Res. 2003, 26, 286-293.
12. Fukuyama, Y.; Kodama, M.; Miura, I.; Kinzyo, Z.; Mori, H.; Nakayama, Y.; Takahashi, H. Antiplasmin inhibitor. VI. Structure of Phlorofucofuroeckol-A, a novel phyrotannin with both Dibenzo-1,4-dioxin and Dibenzofuran elements, from Ecklonia-Kurome Okamura. Chem. Pharm. Bull. 1990, 38, 133-135.
13. Fukuyama, Y.; Kodama, M.; Miura, I.; Kinzyo, Z.; Kido, M.; Mori, H.; Nakayama, Y.; Takahashi, H. Antiplasmin inhibitor. V. Structures of novel dimeric eckols isolated from the brown alga Ecklonia-Kurome Okamura. Chem. Pharm. Bull. 1989, 37, 349-353.
14. Lee, J.H.; Kim, N.D.; Choi, J.S.; Kim, Y.J.; Moon, Y.H.; Lim, S.Y.; Park, S.Y. Inhibitory effects of the methanolic extract of anedible brown alga, Ecklonia stolonifera and its component, phlorglucinol on aflatoxin B1 mutagenicity in vitro (Ames test) and on benzo(a)pyrene or N-methyl N-nitrosourea clastogenicity in vivo (mouse micronucleus test). Nat. Prod. Sci. 1998, 4, 105-114.
15. Nagayama, K.; Iwamura, Y.; Shibata, T.; Hirayama, I.; Nakamura, T. Bactecidal activity of phlorotannins from the brown alga Ecklonia kurome. J. Antimicrob. Chemother. 2002, 50, 889-893. (Pubitemid 36032809)
16. Ahn, M.J.; Yoon, K.D.; Min, S.Y.; Lee, J.S.; Kim, J.H.; Kim, T.G.; Kim, S.H.; Kim, N.G.; Huh, H.; Kim, J. Inhibition of HIV-1 reverse transcriptase and proteases by phlorotannins from brown alga Ecklonia cava. Biol. Pharm. Bull. 2004, 27, 544-547. (Pubitemid 41701842)
17. Kang, H.S.; Kim, H.R.; Byun, D.S.; Son, B.W.; Nam, T.J.; Choi, J.S. Tyrosinase inhibitors isolated from edible brown alga Ecklonia storonifera. Arch. Pharm. Res. 2004, 27, 1226-1232.
18. Heo, S.J.; Park, E.J.; Lee, K.W.; Joen, Y.J. Antioxidant activities of enzymatic extracts from brown seaweeds. Bioresour. Technol. 2005, 96, 1613-1623.
19. Garcia-Trevijano, E.R.; Iraburu, M.J.; Fontana, L.; Dominguez-Rosales, J.A.; Auster, A.; Covarrublas-Pinedo, A.; Rojkind, M. Transforming growth factor beta(1) induces the expression of alpha 1(I) procollagen mRNA by a hydrogen peroxide-C/EBP beta-dependent mechanism in rat hepatic stellate cells. Hepatology 1999, 29, 960-970. (Pubitemid 29109616)
20. Gressner, A.M.; Weiskirchen, R.; Breitkopf, K.; Dooley, S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002, 7, 793-807.
21. Targher, G.; Marra, F.; Marchesini, G. Incresed risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon? Diabetologia 2008, 51, 1947-1953.
22. Nan, Y.-M.; Fu, N.; Wu, W.-J.; Liang, B.-L.; Wang, R.-Q.; Zhao, S.-X.; Zhao, J.-M.; Yu, J. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand. J. Gastroenterol. 2009, 44, 358-365.
23. Friedman, S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275, 2247-2250. (Pubitemid 30081976)
24. Gressner, A.M. The cell biology of liver fibrogenesis - An imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res. 1998, 392, 447-452. (Pubitemid 28282456)
25. Liu, X.; Hu, H.; Yin, J.Q. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int. 2006, 26, 8-22.
26. Breitkopf, K.; Haas, S.; Wiercinska, E.; Singer, M.V.; Dooley, S. Anti-TGF-beta strategies for treatment of chronic liver disease, Alcohol. Clin. Exp. Res. 2005, 29, 121-131.
27. Nakamura, T.; Ueno, T.; Sakamoto, M.; Sakata, R.; Torimura, T.; Hashimoto, O.; Ueno, H.; Sata, M. Suppression of transforming growth factor-beta results in upregulation of transcription of regeneration factors after chronic liver injury. J. Hepatol. 2004, 41, 974-982. (Pubitemid 39575665)
28. Nakamura, T.; Sakata, R.; Ueno, T.; Sata, M.; Ueno, H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000, 32, 247-255. (Pubitemid 30614657)
29. Inagaki, Y.; Truter, S.; Ramirez, F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains a Sp1-binding site. J. Biol. Chem. 1994, 269, 14828-14834.
30. Rahman, I.; MacNee, W. Oxidative stress and regulation of glutathione in lung inflammation. Eur. Respir. J. 2000, 16, 534-554.
31. Kang, K.A.; Zhang, R.; Chae, S.; Lee, S.J.; Kim, J.; Kim, J.; Jeong, J.; Lee, J.; Shin, T.; Lee, N.H.; Hyun, J.W. Phloroglusinol (1,3,5- trihydroxybenzene) protects against ionizing radiation-induced cell damage through inhibition of oxidative stress in vitro and in vivo. Chem. Biol. Interact. 2010, 185, 215-226.
32. Regan, M.A.; Glombitza, K.W. Handbook of Physiological Methods; Cambridge University Press: Cambridge, UK, 1986; pp. 129-241.
33. Ahn, G.N.; Kim, K.N.; Cha, S.H.; Song, C.B.; Lee, J.; Hoe, M.S.; Yeo, I.K.; Lee, N.H.; Jee, Y.H.; Kim, J.S.; Heu, M.S.; Jeon, Y.J. Antioxidant activities of phlorotannins purified from Ecklonia cava on free radical scavenging using ESR and H2O2-mediated DNA damage. Eur. Food Res. Technol. 2007, 226, 71-76.
34. Kojima-Yuasa, A.; Ohkita, T.; Ichikawa, H.; Takami, N.; Nakatani, T.; Kennedy, D.O.; Nishiguchi, S.; Matsui-Yuasa, I. Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells. Chem. Biol. Interact. 2003, 146, 89-99. (Pubitemid 36929773)
35. Sack, R.; Willi, A.; Hunziker, P.E. Determination of total glutathione in cell lysates by high performance liquid chromatography with O-phthalaldehyde precolumn derivatization in the presence of tris(1-carboxyethyl)-phosphate. J. Liq. Chromatogr. Relat. Technol. 2000, 23, 2947-2962. (Pubitemid 32973381)
36. Royall, J.A.; Ischiropoulos, H. Evaluation of 2′,7′- dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch. Biochem. Biophys. 1993, 302, 348-355. (Pubitemid 23212681)
37. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279, L1005-L1028. (Pubitemid 32009487)
38. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
39. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipidperoxide in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358. (Pubitemid 9194347)